Search
gadopentetate dimeglumine (Magnevist, Resovist)
Tradename: Magnevist.
Indications:
- head imaging
- contrast enhancement used with magnetic resonance imaging in patients with intracranial lesions with abnormal vascularity or lesions thought to affect the blood-brain barrier
Injection: 470 mg/mL (10 mL, 15 mL, 20 mL)
Adverse effects:
1) hypotension
2) headache
3) dizziness
4) seizures
5) nausea
6) tinnitus
General
gadolinium contrast (Omniscan)
Database Correlations
PUBCHEM correlations
References
Kaiser Permanente Northern California Regional Drug
Formulary, 1998